Fig. 4From: Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomesA–D Total, self-care, respiration and sphincter management, and mobility SCIM III scores in total population. E–H Total, self-care, respiration and sphincter management, and mobility SCIM III scores in thoracic patients (*p-value ≤ 0.05; **p-value ≤ 0.01)Back to article page